Immunofluorescence Assay Market Size 2022-28: Growth, Trends, Global Share Analysis

According to Precision Business Insights (PBI), latest report, the immunofluorescence assay market is expected to be valued at USD 2,786.4 million in 2022, growing at an 6.5% CAGR from 2022 to 2028. The primary driver of the expansion of the global Immunofluorescence Assay market is a high prevalence of chronic diseases and rising investments in R&D activities & healthcare expenditure.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/immunofluorescence-assay-market/

Cancer Segment to Dominate the Immunofluorescence Assay Market:
Based on diseases, cancer accounted for the maximum share of the global immunofluorescence assay market, owing to the rise in the prevalence of cancer worldwide, and the wides range acceptance of immunofluorescence techniques for the study and diagnosis of cancer.

North America Immunofluorescence Assay Market:
North America region is expected to have a significant share primarily attributed to the increasing incidence of chronic & infectious diseases, increasing R&D expenditure, various government funding, and the existence of major prominent players in the region. The Asia Pacific is also expected to be the fastest growing region for the global Immunofluorescence Assay market over the forecasted period owing to the growing patient population, increasing incidence of chronic diseases, improvement in healthcare infrastructure by huge investment, and increasing research & development activities in biotechnology sector influence the market in this region. Additionally, with the presence of key market players in China, India, and Japan would expect to expand the immunofluorescence market.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Immunofluorescence Assay market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In July 2020, Ultivue Inc. which is a leading biotechnology company that specialized in diagnostics, tissue imaging, and multiplexing has announced a partnership with OracleBio which is a leading company in quantitative digital pathology and provides image analysis services. The aim of this partnership is to improve personalized tumor characterization for drug research and development in translational and clinical oncology.

Request sample report at: https://precisionbusinessinsights.com/request-sample?product_id=58888

The immunofluorescence Assay market is segmented based on product, type, disease, end user, and geography.
Based on the product, the market is segmented into the following:
• Antibodies
• Reagents
• Kits
• Instruments
• Consumables and Accessories

Based on the type, the market is segmented into the following:
• Indirect Immunofluorescence
• Direct Immunofluorescence

Based on the disease, the market is segmented into the following:
• Cancer
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Other Diseases

Based on the end user, the market is segmented into the following:
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Hospitals & Diagnostic Centers

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=58888

Key players' profiles in the immunofluorescence assay market report are Thermo Fisher Scientific, Inc. (US), Abcam plc (UK), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Merck KGaA (Germany), Werfen Company (Spain), Cell Signaling Technology, Inc. (US), MEDIPAN GmbH (Germany), Sino Biological, Inc. (China), Danaher Corporation (US), Maravai Life Sciences (US), and Enzo Biochem, Inc. (US).

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.